Related Experiment Video
Updated: Aug 19, 2025

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Is thrombocytopenia and postnatal weight gain associated with treatment-requiring retinopathy of prematurity? A
Aikaterini K Seliniotaki1,2, Maria Lithoxopoulou3, Stella Moutzouri1
12nd Department of Ophthalmology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Insights
Platelet transfusions increase the risk of treatment-requiring retinopathy of prematurity (TR-ROP). Higher platelet counts and improved postnatal weight gain are associated with a decreased TR-ROP risk in infants.
Area of Science:
- Neonatal Medicine
- Hematology
- Ophthalmology
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Understanding factors associated with treatment-requiring ROP (TR-ROP) is crucial for early intervention.
Purpose of the Study:
- To investigate the association between platelet parameters, postnatal weight gain, and the development of TR-ROP.
- To identify potential biomarkers for predicting TR-ROP in high-risk infants.
Main Methods:
- Retrospective matched case-control study design.
- Inclusion of infants with TR-ROP and matched controls without ROP.
- Collection of longitudinal data on platelet count (PLT), mean platelet volume (MPV), weight, and platelet transfusions.
- Calculation of platelet mass index (PMI) and weight standard deviation score (WSDS).
Main Results:
- Increased platelet count (PLT) during early postnatal life was associated with decreased odds of TR-ROP.
- Infants receiving platelet transfusions had significantly higher odds of developing TR-ROP.
- Higher platelet mass index (PMI) and improved weight gain (WSDS) were linked to reduced TR-ROP risk.
- Mean platelet volume (MPV) and thrombopenic episodes showed no association with TR-ROP.
Conclusions:
- Platelet transfusions may be associated with an increased risk of type I ROP.
- Platelet parameters and postnatal weight gain are potential indicators for TR-ROP development.
- Further prospective studies are needed to confirm these associations and guide clinical practice.
Purpose:
The purpose of the study was to investigate the association of platelet parameters and postnatal weight gain with treatment-requiring ROP (TR-ROP).
Methods:
In this retrospective matched case-control study, infants with TR-ROP were individually matched, according to gestational age and birth weight, with one or two untreated infants who developed no or spontaneously regressed ROP. Longitudinal data on platelet count (PLT), mean platelet volume (MPV), daily weight and platelet transfusions were collected. Platelet mass index (PMI) and weight standard deviation score (WSDS) were also calculated. Conditional logistic regression analysis was performed to adjust for matching.
Results:
Fourteen cases, presenting type I ROP, and 25 matched controls were included. The odds of developing TR-ROP decreased as PLT increased during 31st week of postmenstrual age (PMA) or during 1st and 2nd week of postnatal age (PNA). The odds of developing TR-ROP were 16.7 times higher in infants receiving at least one platelet transfusion compared with those who were not transfused. The odds of developing TR-ROP increased by 31.2% as the mean volume of platelet transfusion per infant increased by 1 ml. The odds of developing TR-ROP decreased as PMI increased during 1st week PNA, and as weight and WSDS increased during 4th -6th week PNA. Analysis of MPV, number of thrombopenic episodes per infant, number of platelet transfusions per infant and days with WSDS < -2 showed no association with TR-ROP.
Conclusion:
To our knowledge, this is the first study ascertaining an association of platelet transfusions with type I ROP. Prospective cohort studies are required to confirm our findings.
Related Concept Videos
Regression Toward the Mean
Teratogenicity
Venous Thrombosis III: Interprofessional Care
Diabetes Mellitus: Type 2 and Gestational

